High perceived stress in patients on opioid agonist therapies during rapid transitional response to the COVID-19 pandemic in Ukraine

BackgroundThe COVID-19 pandemic resulted in marked disruptions in healthcare delivery in Ukraine related to emergency guidance in response to treating opioid use disorder (OUD). Patients with OUD, a group with high levels of comorbid medical and psychiatric disorders, and prescribed opioid agonist t...

Full description

Bibliographic Details
Main Authors: Samy J. Galvez, Frederick L. Altice, Anna Meteliuk, Roman Ivasiy, Eteri Machavariani, Scott O. Farnum, Tetiana Fomenko, Zahedul Islam, Lynn M. Madden
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-11-01
Series:Frontiers in Public Health
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2023.1231581/full
_version_ 1827383674716291072
author Samy J. Galvez
Frederick L. Altice
Frederick L. Altice
Frederick L. Altice
Anna Meteliuk
Roman Ivasiy
Eteri Machavariani
Scott O. Farnum
Tetiana Fomenko
Zahedul Islam
Lynn M. Madden
Lynn M. Madden
author_facet Samy J. Galvez
Frederick L. Altice
Frederick L. Altice
Frederick L. Altice
Anna Meteliuk
Roman Ivasiy
Eteri Machavariani
Scott O. Farnum
Tetiana Fomenko
Zahedul Islam
Lynn M. Madden
Lynn M. Madden
author_sort Samy J. Galvez
collection DOAJ
description BackgroundThe COVID-19 pandemic resulted in marked disruptions in healthcare delivery in Ukraine related to emergency guidance in response to treating opioid use disorder (OUD). Patients with OUD, a group with high levels of comorbid medical and psychiatric disorders, and prescribed opioid agonist therapies (OAT) were rapidly shifted to take-home dosing if they were deemed clinically stable. The impact of these shifts on patient stress and related substance use during the pandemic, however, is unknown.MethodsIn early May 2020, 269 randomly selected OAT patients in Ukraine were surveyed to assess their stress level and substance use using the validated Perceived Stress Scale and examined correlates of severe perceived stress.ResultsOverall, 195 (72.5%) met criteria for moderate to severe levels of stress, which was independently correlated with having started OAT within the past 12 months (aOR: 1.33; 95%CI: 1.15–1.55), living in a large metropolitan area (aOR: 1.31; 95%CI: 1.18–1.46), having been asked by others to share their medication (aOR: 1.13; 95%CI: 1.02–1.25), and having an increase of over 10 min in transportation time to get to treatment (aOR: 1.16; 95%CI: 1.04–1.29). Twenty seven (10%) patients felt at high risk of relapse, while 24 (8.9%) patients reported purchasing drugs.ConclusionDuring a time of great uncertainty soon after emergency guidance to the COVID-19 pandemic, there was extraordinary high levels of perceived stress reported. In response to emergency guidance, OAT patients should be screened for perceived stress and certain subgroups should be targeted for additional psychosocial support.
first_indexed 2024-03-08T14:44:44Z
format Article
id doaj.art-30bc0a2c93f04570bd3b5f1e1c76c34f
institution Directory Open Access Journal
issn 2296-2565
language English
last_indexed 2024-03-08T14:44:44Z
publishDate 2023-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Public Health
spelling doaj.art-30bc0a2c93f04570bd3b5f1e1c76c34f2024-01-11T13:53:55ZengFrontiers Media S.A.Frontiers in Public Health2296-25652023-11-011110.3389/fpubh.2023.12315811231581High perceived stress in patients on opioid agonist therapies during rapid transitional response to the COVID-19 pandemic in UkraineSamy J. Galvez0Frederick L. Altice1Frederick L. Altice2Frederick L. Altice3Anna Meteliuk4Roman Ivasiy5Eteri Machavariani6Scott O. Farnum7Tetiana Fomenko8Zahedul Islam9Lynn M. Madden10Lynn M. Madden11Yale School of Medicine, Section of Infectious Diseases, New Haven, CT, United StatesYale School of Medicine, Section of Infectious Diseases, New Haven, CT, United StatesDivision of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, United StatesAPT Foundation, New Haven, CT, United StatesAlliance for Public Health of Ukraine, Kyiv, UkraineYale School of Medicine, Section of Infectious Diseases, New Haven, CT, United StatesYale School of Medicine, Section of Infectious Diseases, New Haven, CT, United StatesAPT Foundation, New Haven, CT, United StatesAlliance for Public Health of Ukraine, Kyiv, UkraineAlliance for Public Health of Ukraine, Kyiv, UkraineYale School of Medicine, Section of Infectious Diseases, New Haven, CT, United StatesAPT Foundation, New Haven, CT, United StatesBackgroundThe COVID-19 pandemic resulted in marked disruptions in healthcare delivery in Ukraine related to emergency guidance in response to treating opioid use disorder (OUD). Patients with OUD, a group with high levels of comorbid medical and psychiatric disorders, and prescribed opioid agonist therapies (OAT) were rapidly shifted to take-home dosing if they were deemed clinically stable. The impact of these shifts on patient stress and related substance use during the pandemic, however, is unknown.MethodsIn early May 2020, 269 randomly selected OAT patients in Ukraine were surveyed to assess their stress level and substance use using the validated Perceived Stress Scale and examined correlates of severe perceived stress.ResultsOverall, 195 (72.5%) met criteria for moderate to severe levels of stress, which was independently correlated with having started OAT within the past 12 months (aOR: 1.33; 95%CI: 1.15–1.55), living in a large metropolitan area (aOR: 1.31; 95%CI: 1.18–1.46), having been asked by others to share their medication (aOR: 1.13; 95%CI: 1.02–1.25), and having an increase of over 10 min in transportation time to get to treatment (aOR: 1.16; 95%CI: 1.04–1.29). Twenty seven (10%) patients felt at high risk of relapse, while 24 (8.9%) patients reported purchasing drugs.ConclusionDuring a time of great uncertainty soon after emergency guidance to the COVID-19 pandemic, there was extraordinary high levels of perceived stress reported. In response to emergency guidance, OAT patients should be screened for perceived stress and certain subgroups should be targeted for additional psychosocial support.https://www.frontiersin.org/articles/10.3389/fpubh.2023.1231581/fullopioid agonist therapiesmethadonebuprenorphinestressCOVID-19Ukraine
spellingShingle Samy J. Galvez
Frederick L. Altice
Frederick L. Altice
Frederick L. Altice
Anna Meteliuk
Roman Ivasiy
Eteri Machavariani
Scott O. Farnum
Tetiana Fomenko
Zahedul Islam
Lynn M. Madden
Lynn M. Madden
High perceived stress in patients on opioid agonist therapies during rapid transitional response to the COVID-19 pandemic in Ukraine
Frontiers in Public Health
opioid agonist therapies
methadone
buprenorphine
stress
COVID-19
Ukraine
title High perceived stress in patients on opioid agonist therapies during rapid transitional response to the COVID-19 pandemic in Ukraine
title_full High perceived stress in patients on opioid agonist therapies during rapid transitional response to the COVID-19 pandemic in Ukraine
title_fullStr High perceived stress in patients on opioid agonist therapies during rapid transitional response to the COVID-19 pandemic in Ukraine
title_full_unstemmed High perceived stress in patients on opioid agonist therapies during rapid transitional response to the COVID-19 pandemic in Ukraine
title_short High perceived stress in patients on opioid agonist therapies during rapid transitional response to the COVID-19 pandemic in Ukraine
title_sort high perceived stress in patients on opioid agonist therapies during rapid transitional response to the covid 19 pandemic in ukraine
topic opioid agonist therapies
methadone
buprenorphine
stress
COVID-19
Ukraine
url https://www.frontiersin.org/articles/10.3389/fpubh.2023.1231581/full
work_keys_str_mv AT samyjgalvez highperceivedstressinpatientsonopioidagonisttherapiesduringrapidtransitionalresponsetothecovid19pandemicinukraine
AT fredericklaltice highperceivedstressinpatientsonopioidagonisttherapiesduringrapidtransitionalresponsetothecovid19pandemicinukraine
AT fredericklaltice highperceivedstressinpatientsonopioidagonisttherapiesduringrapidtransitionalresponsetothecovid19pandemicinukraine
AT fredericklaltice highperceivedstressinpatientsonopioidagonisttherapiesduringrapidtransitionalresponsetothecovid19pandemicinukraine
AT annameteliuk highperceivedstressinpatientsonopioidagonisttherapiesduringrapidtransitionalresponsetothecovid19pandemicinukraine
AT romanivasiy highperceivedstressinpatientsonopioidagonisttherapiesduringrapidtransitionalresponsetothecovid19pandemicinukraine
AT eterimachavariani highperceivedstressinpatientsonopioidagonisttherapiesduringrapidtransitionalresponsetothecovid19pandemicinukraine
AT scottofarnum highperceivedstressinpatientsonopioidagonisttherapiesduringrapidtransitionalresponsetothecovid19pandemicinukraine
AT tetianafomenko highperceivedstressinpatientsonopioidagonisttherapiesduringrapidtransitionalresponsetothecovid19pandemicinukraine
AT zahedulislam highperceivedstressinpatientsonopioidagonisttherapiesduringrapidtransitionalresponsetothecovid19pandemicinukraine
AT lynnmmadden highperceivedstressinpatientsonopioidagonisttherapiesduringrapidtransitionalresponsetothecovid19pandemicinukraine
AT lynnmmadden highperceivedstressinpatientsonopioidagonisttherapiesduringrapidtransitionalresponsetothecovid19pandemicinukraine